Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Easier Listing Requirements To Attract Korean Biopharma IPOs

This article was originally published in PharmAsia News

Executive Summary

With a number of large South Korean biopharma IPOs expected this year, South Korea's benchmark Kospi and second-tier Kosdaq markets appear to be vying to attract the IPOs to their markets by easing listing regulations.



Related Companies